Myriad Genetics (MYGN) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY25 Guidance
Go back to Myriad Genetics (MYGN) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY25 Guidance| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.57 +0.03 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.54 | 52 Week High | $45.34 | |||
| Open | $4.54 | 52 Week Low | $15.92 | |||
| Day High | $4.62 | P/E | 1.96 | |||
| Day Low | $4.42 | EPS | $2.33 | |||
| Volume | 427,874 | |||||
